We invite all our readers to take part in our Hybridan Newsletters
and Equity Research Survey by clicking on the link: here
* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
Admissions:
None
Delistings:
None
What’s baking in the oven?
Potential IPOs:***
3 June: Reveille Resources has announced its intention to IPO onto AQSE. The strategy is focused on identifying and advancing uranium exploration opportunities in assets that have benefited from significant historical expenditure and technical work, but which may not have achieved full value realisation due to geopolitical, technological, financial, or historical factors. Reveille’s initial focus is on two historical uranium deposits in Lombardy, northern Italy. Deal details TBC and expected Admission date is 17 June.
21 May: Coastal Africa Group, a newly formed incorporated Company focused on acquiring and investing in the oil and gas sector, energy infrastructure, energy services and energy assets across West Africa, has announced its intention to IPO onto AIM. £17.4m will be raised on Admission with an anticipated market capitalisation of £218m. The expected Admission date is 10th June.
17 March: Vista Parcs Group has announced its intention to IPO onto AIM. The newly incorporated entity is proposing to acquire a portfolio of 13 UK-based holiday and residential parks currently owned by Barney Group 2 Ltd (BG2) and operated by Baslow Parks Ltd. Deal details TBC and expected Admission date anticipated late June 2026.
Reverse Transactions:***
19th December 2025: Talon Resources (TAR.L), previously Medcaw Investments, the Company focused on identifying and acquiring prospective mining projects in the precious metals sector, with a primary focus on gold and other high-value commodities announced that it has entered into binding heads of terms (which includes an exclusivity agreement until 31 October 2026) with Ulvestone Ltd in respect of the proposed acquisition by the Company of 90% of the legal and beneficial interest in certain mineral exploration licences located in Ontario, Canada. The aggregate consideration payable by Medcaw is £4.17m, to be satisfied £70k in cash on execution of the definitive share purchase agreement, £100k in cash on AIM Admission, and £4m satisfied through the issue of new ordinary shares in Medcaw at a price of 1.5p per share, to be issued on AIM Admission. The indicative timetable in relation to the Cancellation and proposed re-admission to trading on AIM has been revised and is now expected to take effect on 23 June.
Market Movers:***
1st June: Mendell Helium (AQSE: MDH), the helium production company with operations in Kansas, announced its intention to move to AIM during the week beginning 15 June. No new Ordinary Shares are being issued or allotted in conjunction with Admission to trading on AIM with an anticipated market capitalisation on Admission of approximately £15m.
Banquet Buffet****
London Stock Exchange: Main Market and AIM
Acuity RM Group 0.95p £2.26m (ACRM.L)
The software group specialising in cyber-security announced a contract expansion with an existing customer, a supplier to the nuclear industry comprising the migration of the customer's on-premises STREAM Classic deployment to STREAM Classic SaaS and the addition of Third Party Risk Management (TPRM) capability. The customer has signed a new three-year contract with a total value in excess of £100,000. The contract comprises both a professional services component, covering the migration and TPRM deployment, and a recurring subscription component. The contract increases the recurring revenue contribution from this customer and extends the customer relationship for a further three years.
Beeks Financial Cloud Group 192.50p £111.05m (BKS.L)
The cloud computing and connectivity provider for financial markets announced that it has secured its first contract for Market Edge Intelligence, the analytics platform that brings AI-powered insight directly to the colocation edge. Following the offering's launch earlier in FY26, and a successful proof of concept, Beeks has signed a 5-year contract with a total value of $4.8m with one of the world's largest banks for deployment of the software in one area of its trading infrastructure. Revenue recognition is set to commence immediately, further supporting the Board's FY26 expectations.
BRCK Group 49.55p £159.67m (BRCK.L)
The construction materials distributor announced that it has entered into a binding agreement to acquire 100% of the issued share capital of H.S. Jackson & Son (Fencing) Limited for an initial consideration of £15m on a cash-free, debt-free, normalised working capital basis. An additional cash payment of £4.9m in respect of the freehold land and property from which Jacksons operates will also be payable on completion. The Initial Consideration and Property Consideration will be funded from existing Company resources. For the year ended 30 September 2025 (unaudited), Jackson & Son generated revenue of approximately £40.9m and EBITDA of approximately £4.2m.
GENinCode 0.95p £8.66m (GENI.L)
The predictive genetics Company focused on the prevention of cardiovascular disease and risk of ovarian cancer reports finals for the FY 31 December 2025. Revenues improved 13.8% to £3.1m helped by increased sales from the US and Europe. The EBITDA loss increased to £4.8m from £4.4m in the prior year. Y/E cash was £0.8m, but since the year end £4.7m of new capital has been raised. The funds are to scale up operations for commercialisation. Commercial discussions with Thermo Fisher regarding pricing and distribution of CARDIO inCode in the US and Europe are in progress. Discussions with the FDA were extended to resolve the outstanding deficiencies in its submission which is expected during Q3 2026.
Marechale Capital 5.70p £5.32m (MAC.L)
The corporate finance advisory business announced that it has received confirmation that the FCA has approved the change in control of Stanford Capital Partners. The application was made to the FCA as a part of the proposed acquisitions, including Stanford, Blubird Global Inc., NJC Capital Management VSA Private Fund Limited and NJC Capital Management Limited, as announced on 3 June 2026, and the approval by the FCA was a contingent term of the acquisition of Stanford. The CEO said these transactions will establish Marechale as a fully integrated digital merchant bank.
Mpac Group 232.5p £78.94m (MPAC.L)
The Company involved in high-speed packaging and automation solutions announced a trading update and the sale of Mpac Lambert Limited. Since 21 April 2026, trading margins have continued to be impacted by delays in customer decision making on capital investments, heightened competitive pricing pressure, and lower operational leverage arising from reduced OE volumes. Accordingly, the Board now expects first half margins to be below the prior year, and FY 2026 underlying profit before tax to be substantially below current market expectations on a like-for-like basis.
MTI Wireless Edge Ltd 69.50p £59.48m (MWE.L)
The technology Company focused on comprehensive communication and radio frequency solutions across multiple sectors announced that further to its announcement on 7 April 2026, P.S.K. Wind Technologies Limited's contract for the supply of communications infrastructure to the Israeli Ministry of Defence has doubled in value, increasing from US$2.2m to approximately US$4.5m. The expanded order is expected to be completed by the end of Q1 2027.
Quantum Blockchain Technologies 0.37p £5.87m (QBT.L)
The investment company focused principally on a research and development programme within blockchain technology updates on ongoing development and testing. The Method C AI Oracle software on the ASIC manufacturer's mining rig and Mining Development Kit is now fully operational and connected to the Company's server infrastructure. The Company can now report that the ASIC manufacturer's mining rig is generating quality data suitable for training QBT's AI learning models. This represents an important milestone in the development of the Method C AI Oracle and enables the Company to commence training the learning models that will generate the next AI Oracle. The first AI Oracle to be generated using this new dataset could be available by the end of June 2026.
Revolution Beauty Group 4.94p £40.44m (REVB.L)
The multi-channel mass beauty brand announced that the Boards of Debenhams Group and Revolution Beauty have agreed a new licensing partnership to develop beauty and fragrance products across Debenhams Group brands. The partnership combines Revolution Beauty's expertise in developing, manufacturing and distributing beauty products with the strength and reach of Debenhams Group's full brand portfolio of fashion and lifestyle brands. The first collections are expected to launch ahead of Christmas and will include fragrance and gifting ranges for PrettyLittleThing, Karen Millen and boohooMAN.
Aquis Market:
Sterling Digital 4.50p £6.73m (AQSE: ASIC)
The Company established to develop low-energy-cost digital asset mining operations in the US, announced that it has entered into a gas purchase agreement with a US based supplier for the supply of natural gas to power its bitcoin mining operations in West Texas, US. The initial term of the Agreement is five years, with the option to extend for up to two further one-year periods. The Company has committed to purchasing a minimum of 96,360 MMBtu of gas per year across the first four years of the Agreement (385,440 MMBtu in aggregate), with the Supplier guaranteeing availability of up to 6,500 MMBtu per day during the initial term.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
